FDA Looks East—Here’s What Industry Needs to Know By Charles D. Snow & Kalie E. Richardson —

https://www.thefdalawblog.com/2026/04/fda-looks-east-heres-what-industry-needs-to-know/?utm_source=rss&utm_medium=rss&utm_campaign=fda-looks-east-heres-what-industry-needs-to-know If you’ve been tracking FDA’s international presence, you know FDA has been through a bit of a roller coaster over the past decade. After consolidating from 13 foreign offices down to 8 between 2012 and 2014—and losing its Pretoria, South Africa office in 2015—the Agency is now back in expansion mode. And the latest moves are worth paying close attention to if your products are manufactured or sourced overseas. For a general overview of FDA’s purpose behind and process for choosing foreign offices, see the Agency’s 2012 Report to Congress on the FDA Foreign Offices. The Government Accountability Office (GAO) has also issued several reports related to improvements needed at FDA’s foreign offices to support inspections of foreign food (2015) and drug (2016 and 2022) facilities.